Information Provided By: 
Fly News Breaks for March 4, 2020
FATE
Mar 4, 2020 | 05:07 EDT
Barclays analyst Peter Lawson initiated coverage of Fate Therapeutics with an Overweight rating and $40 price target.
News For FATE From the Last 2 Days
FATE
Apr 18, 2024 | 17:52 EDT
Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSMetropolitan... To see the rest of the story go to thefly.com. See Story Here
